...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Novo Nordisk: Novo Interesting

If 208 has positive results from the BETonMACE its adoption into the clinical world is driven by Evidence Based Medicine. This is one trial in a high need, select patient population. Others trials and indications surely to follow.

Pup

Share
New Message
Please login to post a reply